<DOC>
	<DOCNO>NCT00001465</DOCNO>
	<brief_summary>Pulmonary lymphangioleiomyomatosis ( LAM ) destructive lung disease typically affect woman childbearing age . Currently , effective therapy disease prognosis poor . This study design determine disease process involve level cell molecule , order develop effective therapy . Researchers intend identify protein gene contribute process lung destruction affect individual .</brief_summary>
	<brief_title>Study Disease Process Lymphangioleiomyomatosis</brief_title>
	<detailed_description>Individuals pulmonary lymphangioleiomyomatosis develop severe destructive lung disease . Most female childbearing age . Currently , proven effective therapy prognosis variable . This study design ( ) define clinical course disease ( b ) elucidate pathogenesis disease cellular molecular level , order develop effective therapy . To accomplish , intend identify protein gene contribute process lung destruction affect individual .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pneumothorax</mesh_term>
	<mesh_term>Tuberous Sclerosis</mesh_term>
	<mesh_term>Lymphangioleiomyomatosis</mesh_term>
	<criteria>INCLUSION CRITERIA : General admission criterion patient include one following : Findings lung biopsy diagnostic LAM ; Findings chest xray and/or chest compute axial tomography consistent LAM . Patients TSC pulmonary LAM include study . Normal nonsmoker control group define individual smoke great equal 1 year systemic pulmonary disease . Normal smoker define individual systemic pulmonary disease , smoke great equal 1 year normal chest xray normal pulmonary function test may include need control similar population patient LAM . EXCLUSION CRITERIA : Exclusion criterion patient include : Age le 16 . Advanced stage pulmonary systemic illness risk study judge significant even absence clear contraindication procedure . Exclusion criterion patient formal exercise study stress echocardiogram include patient continuous oxygen . Patients may perform exercise test ass patient 's exercise capacity activity daily live .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 16, 2016</verification_date>
	<keyword>Smooth Muscle Proliferation</keyword>
	<keyword>Bronchoscopy</keyword>
	<keyword>Female</keyword>
	<keyword>Pneumothorax</keyword>
	<keyword>Tuberous Sclerosis</keyword>
	<keyword>Lymphangioleiomyomatosis ( LAM )</keyword>
</DOC>